Pharmacokinetic profile of the synthetic mu-opioid receptor agonist [Lys7]Dermorphin-IRDye(R)800CW and its feasibility as a biomarker for opioid use disorder https://www.biorxiv.org/content/10.1101/2023.06.19.545627v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.